IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q2 2025 Holdings

Filed 2025-07-08 | 5 holdings | $427.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$262.3M19,963,15761.4%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$71.6M7,464,57216.8%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$52.0M2,869,56512.2%
Rapt Therapeutics Inc(RAPT)COM75382E208$22.4M2,794,0005.2%
Aura Biosciences Inc(AURA)COM05153U107$19.0M3,039,8924.5%